Nuveen’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$469 Buy
+295
New +$1.02K ﹤0.01% 4989
2025
Q2
– Sell
-2,924
Closed -$37.2K – 3442
2025
Q1
$37.2K Hold
2,924
– – ﹤0.01% 3269
2024
Q4
$66.2K Hold
2,924
– – ﹤0.01% 3308
2024
Q3
$91.5K Hold
2,924
– – ﹤0.01% 3312
2024
Q2
$187K Buy
+2,924
New +$278K ﹤0.01% 3230

Other funds holding SKYE

Nuveen's SKYE Position: Q3 2026 in Review

Nuveen opened a new position in Skye Bioscience (SKYE) in Q3 2026: 295 shares worth $469. The stake represents ﹤0.01% of the portfolio and ranks #4989 among its holdings. This is a return to the name: Nuveen previously reported a position in SKYE as recently as Q1 2025.

Nuveen first reported a position in SKYE in Q2 2024 and has held it in 5 quarters since. The position peaked at $187K in Q2 2024. 31 funds tracked by Wall St. Rank hold SKYE as of Q3 2026.

  • Nuveen held 295 shares of Skye Bioscience worth $469 as of Q3 2026.
  • Skye Bioscience was a new Nuveen position in Q3 2026.
  • Skye Bioscience made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4989 holding.
  • Nuveen first reported a position in Skye Bioscience in Q2 2024 and has held it in 5 quarters since.
  • Nuveen's Skye Bioscience position peaked at $187K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.